Bio Green Med Solution is trading 10.29% up at $0.99 after an amended S-4/A filing advanced its proposed all-stock acquisition of Future NRG.

  • The September 11 filing included auditor consent and additional Future NRG financial information, improving transaction-readiness.
  • The deal carries a reported $2 billion headline valuation and remains subject to shareholder, regulatory, registration, and customary closing conditions.
  • Completion is expected in the fourth quarter of 2026.